Extracellular ATP and Toll-like receptor 2 agonists trigger in human monocytes an activation program that favors T helper 17.

by Christopher Paustian, Patricia Taylor, Terrence Johnson, Min Xu, Nancy Ramirez, Kenneth S Rosenthal, Suyu Shu, Peter A Cohen, Brian J Czerniecki, Gary K Koski
Published 2013-01-01

HER3 Expression Is a Marker of Tumor Progression in Premalignant Lesions of the Gastroesophageal Junction.

by Brett L Ecker, Laura Taylor, Paul J Zhang, Emma E Furth, Gregory G Ginsberg, Matthew T McMillan, Jashodeep Datta, Brian J Czerniecki, Robert E Roses
Published 2016-01-01

Personalizing Radiation Treatment Delivery in the Management of Breast Cancer

by Kamran A. Ahmed, G. Daniel Grass, Amber G. Orman, Casey Liveringhouse, Michael E. Montejo, Hatem H. Soliman, Heather S. Han, Brian J. Czerniecki, Javier F. Torres-Roca, Roberto Diaz
Published 2018-01-01

Utilizing the genomically adjusted radiation dose (GARD) to personalize adjuvant radiotherapy in triple negative breast cancer managementResearch in context

by Kamran A. Ahmed, Casey L. Liveringhouse, Matthew N. Mills, Nicholas B. Figura, G. Daniel Grass, Iman R. Washington, Eleanor E. Harris, Brian J. Czerniecki, Peter W. Blumencranz, Steven A. Eschrich, Jacob G. Scott, Roberto Diaz, Javier F. Torres-Roca
Published 2019-09-01